Page last updated: 2024-08-05 12:13:58
trifluoroacetamide
null
ChEBI ID: 145723
Members (9)
Member | Definition | Role |
2,2,2-trifluoro-N-(2-methyl-8-quinolinyl)acetamide | | 2,2,2-trifluoro-N-(2-methyl-8-quinolinyl)acetamide |
2,2,2-trifluoro-N-(5-oxo-1-phenyl-4H-pyrazol-3-yl)acetamide | | 2,2,2-trifluoro-N-(5-oxo-1-phenyl-4H-pyrazol-3-yl)acetamide |
2,2,2-trifluoro-N-[2-(1H-indol-3-yl)ethyl]acetamide | | 2,2,2-trifluoro-N-[2-(1H-indol-3-yl)ethyl]acetamide |
N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-4-ylethyl]-2,2,2-trifluoroacetamide | | N-(1,3-benzodioxol-5-ylmethyl)-N-[2-(cyclohexylamino)-2-oxo-1-pyridin-4-ylethyl]-2,2,2-trifluoroacetamide |
N-[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-2,2,2-trifluoro-N-(4-methylphenyl)acetamide | | N-[2-(cyclohexylamino)-2-oxo-1-thiophen-2-ylethyl]-2,2,2-trifluoro-N-(4-methylphenyl)acetamide |
N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide | | N-[3-(N-(2-chloro-1-oxoethyl)-4-nitroanilino)propyl]-2,2,2-trifluoroacetamide |
n-methyl-n-(tert-butyldimethylsilyl)trifluoroacetamide | An N-silyl compound that is N-methyltrifluoroacetamide in which the amide nitrogen is replaced by a tert-butyldimethylsilyl group. | N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide |
n-methyl-n-(trimethylsilyl)trifluoroacetamide | An N-silyl compound that is N-methyltrifluoroacetamide in which the amide nitrogen is replaced by a trimethylsilyl group. N-methyl-N-(trimethylsilyl)trifluoroacetamide is a derivatisation agent used in gas chromatography/mass spectrometry applications. | N-methyl-N-(trimethylsilyl)trifluoroacetamide |
valrubicin | | valrubicin |
Research
Studies (194)
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
pre-1990 | 41 (21.13) | 18.7374 |
1990's | 32 (16.49) | 18.2507 |
2000's | 52 (26.80) | 29.6817 |
2010's | 59 (30.41) | 24.3611 |
2020's | 10 (5.15) | 2.80 |
Study Types
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
Trials | 7 (2.99%) | 5.53% |
Reviews | 15 (6.41%) | 6.00% |
Case Studies | 2 (0.85%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 210 (89.74%) | 84.16% |